Author:
Dansirikul Chantaratsamon,Silber Hanna E.,Karlsson Mats O.
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Aarons L, Baxter C, Gupta S (2004) Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions. Biopharm Drug Dispos 25: 219–225
2. Comets E, Mentre F, Grass P, Kawai R, Marbach P, Vonderscher J (2003) Population pharmacodynamic analysis of octreotide in acromegalic patients. Clin Pharmacol Ther 73: 95–106
3. Furuya A, Nozawa M, Gotoh J, Jingu S, Akimoto M, Higuchi S, Suwa T, Ogata H (2002) Pharmacokinetic and pharmacodynamic analysis of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs. J Pharm Pharmacol 54: 921–927
4. Hugh BM, Frey N (2004) Population PK and PK/PD analyses of an enzyme inhibitor in healthy volunteers. In: PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe, Sweden
5. Karlsson MO, Wade JR, Loumaye E, Munafo A (1998) The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women. Br J Clin Pharmacol 45: 13–20
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献